EWTX - Edgewise Therapeutics GAAP EPS of -$0.34 beats by $0.02 November, 03 2022 09:29 AM Edgewise Therapeutics Inc. Edgewise Therapeutics press release ( NASDAQ: EWTX ): Q3 GAAP EPS of -$0.34 beats by $0.02 . Cash, cash equivalents and marketable securities were $365 million as of September 30, 2022. For further details see: Edgewise Therapeutics GAAP EPS of -$0.34 beats by $0.02